retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide for Weight Loss: 2026

The initial pivotal studies that led to the first wave of GLP-1 RAs demonstrated that they work in several ways, including stimulating insulin release, slowing digestion, reducing appetite, and inhibiting glucagon release

We lose not only fat, but also muscle mass as rapidly as fat tissue, Sceppa says

J Endocrinol (2017) 233(1):R4351

Samantha Snashall, a registered dietitian at Ohio State Wexner Medical Center, warns: "Be careful if the volume on the food noise goes down so low while on a GLP-1 that you forget to eat three meals and a couple of snacks a day

It is whether the medication is approved for the intended use, fits your health history, and can be monitored through a legitimate clinical pathway

WeightWatchers lists a standard Med+ plan price of $74 per month on its weight-loss medication page, though medication cost and coverage can vary